Skip to main content
SpringerLink
Log in

CIS and Bilateral Cancer: Clinical Presentation and Diagnostics

  • Chapter
  • First Online:
Cancer of the Testis

Abstract

On Line Abstract The incidence of testis cancer is increasing in many countries at an average annual rate of rise of 2-5%. In addition, patients with testis cancer have a higher rate of developing contralateral tumors than the general population, making the issue of bilateral testis cancer a clinical concern of increasing importance. This chapter focuses on the prevalence, diagnosis, treatment and etiology of bilateral testis cancer and investigates how patterns of occurrence might reflect on etiologic factors and mechanisms of tumor development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Almstrup K, Hoei-Hansen CE, Wirkner U et al (2004) Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64:4736–4743

    Article  PubMed  CAS  Google Scholar 

  • Almstrup K, Hoei-Hansen CE, Nielsen JE et al (2005) Differences in genome-wide gene expression profiles of testicular carcinoma in situ and invasive germ cell tumours. Br J Cancer 92:1934–1941

    Article  PubMed  CAS  Google Scholar 

  • Andrews PW (1998) Teratocarcinomas and human embryology: pluripotent human EC cell lines. APMIS 106:158–168

    Article  PubMed  CAS  Google Scholar 

  • Berthelsen JG, Skakkebaek NE, Mogensen P et al (1979) Incidence of carcinoma in situ of germ cells in contralateral testis of men with testicular tumours. Br Med J 2:363–364

    Article  PubMed  CAS  Google Scholar 

  • Berthelsen JG, Skakkebæk NE, von der Maase H et al (1982) Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br Med J 285:1683–1686

    Article  CAS  Google Scholar 

  • Bray F, Ferlay J, Devesa SS et al (2006) Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 3:532–543

    Article  PubMed  Google Scholar 

  • Christensen TB, Daugaard G, Geertsen PF et al (1998) Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 9:657–660

    Article  PubMed  CAS  Google Scholar 

  • Clark AT, Rodriguez RT, Bodnar MS et al (2004) Human STELLAR, NANOG and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 22:169–179

    Article  PubMed  CAS  Google Scholar 

  • Classen J, Dieckmann KP (2002) Radiotherapy of carcinoma-in-situ of the testis. J Clin Oncol 20:3559–3560

    Article  PubMed  Google Scholar 

  • Dieckmann K-P, Loy V (1996) Prevalence of contralateral testicular intraepithelial germ cell neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 14:3126–3132

    PubMed  CAS  Google Scholar 

  • Dieckmann KP, Lauke H, Michl U, Winter E, Loy V (2002) Testicular germ cell cancer despite previous local radiotherapy to the testis. Eur Urol 41:643–649; discussion 649–650

    Article  PubMed  Google Scholar 

  • Dieckmann KP, Kulejewski M, Pichlmeier U et al (2007) Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 51:175–183

    Article  PubMed  Google Scholar 

  • Dong C, Lonnstedt I, Hemminki K (2001) Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 37:1878–1885

    Article  PubMed  CAS  Google Scholar 

  • Ezeh UI, Turek PJ, Reijo Pera RA et al (2005) Seminoma and breast cancer have expression profiles similar to pluripotent stem cells. Cancer 104:2255–2265

    Article  PubMed  CAS  Google Scholar 

  • Fossa SD, Aass N (1989) Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer. Br J Urol 63:531–534

    Article  PubMed  CAS  Google Scholar 

  • Fossa SD, Chen J, Schonfeld SJ et al (2005) Risk of contralateral testicular cancer: a population-based study of 29515 U.S. men. J Natl Cancer Inst 97:1056–1066

    Article  PubMed  Google Scholar 

  • Geczi L, Gomez F, Bak M et al (2003) The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. J Cancer Res Clin Oncol 129:309–315

    PubMed  Google Scholar 

  • Harland SJ, Cook PA, Fossa SD et al (1998) Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol 160:1353–1357

    Article  PubMed  CAS  Google Scholar 

  • Harland SJ, Rapley EA, Nicholson PW (2007) Do all patients with bilateral testis cancer have a hereditary predisposition? Int J Androl 30(4):251–255; discussion 255

    Article  PubMed  CAS  Google Scholar 

  • Hartmann JT, Fossa SD, Nichols CR et al (2001) Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst 93:1733–1738

    Article  PubMed  CAS  Google Scholar 

  • Hemminki K, Li X (2004) Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 90:1765–1770

    Article  PubMed  CAS  Google Scholar 

  • Hentrich M, Weber N, Bergsdorf T et al (2005) Management and outcome of bilateral testicular germ cell tumors: twenty five year experience in Munich. Acta Oncol 44:529–536

    Article  PubMed  Google Scholar 

  • Hoei-Hansen CE, Carlsen E, Jørgensen N et al (2007) Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers. Hum Reprod 22:167–173

    Article  PubMed  CAS  Google Scholar 

  • Kemmer K, Corless CL, Fletcher JA et al (2004) KIT mutations are common in testicular seminomas. Am J Pathol 164:305–313

    Article  PubMed  CAS  Google Scholar 

  • Kliesch S, Thomaidis T, Schutte B et al (2003) Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN). APMIS 111:70–74; discussion 75

    Article  PubMed  Google Scholar 

  • Korkola JE, Houldsworth J, Chadalavada RS et al (2006) Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66:820–827

    Article  PubMed  CAS  Google Scholar 

  • Looijenga LH, Stoop H, de Leeuw HP et al (2003a) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244–2250

    PubMed  CAS  Google Scholar 

  • Looijenga LHJ, De Leeuw PJC, Van Oorschot M et al (2003b) Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ cell tumors. Cancer Res 63:7674–7678

    PubMed  CAS  Google Scholar 

  • Madani A, Kemmer K, Sweeney C et al (2003) Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors. Ann Oncol 14:873–880

    Article  PubMed  CAS  Google Scholar 

  • McIntyre A, Summersgill B, Grygalewicz B et al (2005) Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65:8085–8089

    Article  PubMed  CAS  Google Scholar 

  • Møller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23:8–15

    PubMed  Google Scholar 

  • Osterlind A, Berthelsen JG, Abildgaard N et al (1991) Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984. J Natl Cancer Inst 83:1391–1395

    Article  PubMed  CAS  Google Scholar 

  • Ottesen AM, Rajpert-De Meyts E, Holm M et al (2004) Cytogenetic and molecular analysis of a family with three brothers afflicted with germ cell cancer. Clin Genet 65:32–39

    Article  PubMed  CAS  Google Scholar 

  • Pamenter B, De Bono JS, Brown IL et al (2003) Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre. BJU Int 92:43–46

    Article  PubMed  CAS  Google Scholar 

  • Petersen PM, Giwercman A, Daugaard G et al (2002) Effect of graded testicular doses of radiotherapy in patients treated for carcinoma in situ. J Clin Oncol 20:1537–1543

    Article  PubMed  Google Scholar 

  • Rajpert-De Meyts E (2006) Developmental model for the pathogenesis of testicular carcinoma in situ: environmental and genetic aspects. Hum Reprod Update 12:303–323

    Article  PubMed  CAS  Google Scholar 

  • Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, Bartek J, Skakkebaek NE (2003) The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 111:267–279

    PubMed  Google Scholar 

  • Rapley EA, Hockley S, Warren W et al (2004) Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 90:2397–2401

    PubMed  CAS  Google Scholar 

  • Skakkebaek NE (1972) Possible carcinoma-in-situ of the testis. Lancet 2:516–517

    Article  PubMed  CAS  Google Scholar 

  • Skakkebaek NE, Berthelsen JG (1981) Carcinoma-in-situ of the testis and invasive growth of different types of germ cell tumours. A revised germ cell theory. Int J Androl 4(Suppl 4):26–34

    Article  Google Scholar 

  • Skakkebaek NE, Berthelsen JG, Giwercman A et al (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28

    Article  PubMed  CAS  Google Scholar 

  • Skakkebaek NE, Rajpert-De Meyts E, Jørgensen N et al (1998) Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS 106:3–12

    Article  PubMed  CAS  Google Scholar 

  • Skotheim RI, Lind GE, Monni O et al (2005) Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65:5588–5598

    Article  PubMed  CAS  Google Scholar 

  • Sperger JM, Chen X, Draper JS et al (2003) Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 100:13350–13355

    Article  PubMed  CAS  Google Scholar 

  • Theodore Ch, Terrier-Lacombe MJ, Laplanche A et al (2004) Bilateral germ-cell tumours: 22-year experience at the ****Institut Gustave Roussy. Br J Cancer 90:55–59

    Article  PubMed  Google Scholar 

  • Tian Q, Frierson HF Jr, Krystal GW et al (1999) Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154:1643–1647

    Article  PubMed  CAS  Google Scholar 

  • van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW et al (1993) Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 11:415–424

    PubMed  Google Scholar 

  • von der Maase H (2005) Is a contralateral testicular biopsy in patients with unilateral germ cell testis cancer indicated as a routine procedure? Acta Oncol 44:523–525

    Article  PubMed  Google Scholar 

  • Von der Maase H, Rorth M, Walbom-Jorgensen S et al (1986a) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 cases. Br Med J 293:1398–1401

    Article  Google Scholar 

  • von der Maase H, Giwercman A, Skakkebaek NE (1986b) Radiation treatment of carcinoma in situ of testis. Lancet 1:624–625

    Article  PubMed  Google Scholar 

  • von der Masse H, Giwercman A, Muller J et al (1987) Management of carcinoma in-situ of testis. Int J Androl 10:209–220

    Article  Google Scholar 

  • Wanderas EH, Fossa SD, Tretli S (1997a) Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 33:244–252

    Article  PubMed  CAS  Google Scholar 

  • Wanderas EH, Fossa SD, Tretli S (1997b) Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 33:253–262

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Turek Clinic, 55 Francisco st, suite 300, San Francisco, CA, 94133, USA

    Paul J. Turek

Authors
  1. Paul J. Turek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ewa Rajpert-De Meyts
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gedske Daugaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niels E. Skakkebaek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul J. Turek .

Editor information

Editors and Affiliations

  1. Academic Medical Center, Dept. Urology, University of Amsterdam, Meibergdreef 9, Amsterdam, 1050 AZ, Netherlands

    M. Pilar Laguna

  2. Urologische Klinik, Klinikum Kassel GmbH, Mönchebergstr. 41-43, Kassel, 34125, Germany

    Peter Albers

  3. Zentrum für Innere Medizin, Klinik für Onkologie, Hämatologie und, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany

    Carsten Bokemeyer

  4. Division of Urology, Brigham & Women’s Hospital, Francis St. 45, Boston, 02115, Massachusetts, USA

    Jerome P. Richie

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Turek, P.J., Meyts, E.RD., Daugaard, G., Skakkebaek, N.E. (2011). CIS and Bilateral Cancer: Clinical Presentation and Diagnostics. In: Laguna, M., Albers, P., Bokemeyer, C., Richie, J. (eds) Cancer of the Testis. Springer, London. https://doi.org/10.1007/978-1-84800-370-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-370-5_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-369-9

  • Online ISBN: 978-1-84800-370-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation